This product is a blood lipid regulating drug of clofibric acid derivatives. It reduces blood low-density lipoprotein, cholesterol and triglycerides by inhibiting the production of very low-density lipoprotein and triglycerides and increasing their catabolism at the same time; it also increases the production of apolipoprotein A1 and A11, thereby increasing high-density lipoprotein. This product also has the effect of reducing blood uric acid in normal people and patients with hyperuricemia. Animal experiments have shown that fenofibrate is teratogenic and carcinogenic.

This product has a broad-spectrum antimicrobial effect in vitro, including aerobic Gram-negative and Gram-positive bacteria, anaerobes, Rickettsia, spirochetes and Chlamydia. It has bactericidal effects on the following bacteria: Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis. It only has antibacterial effects on the following bacteria: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Group B hemolytic Streptococcus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella typhi, Salmonella paratyphi, Shigella, Bacteroides fragilis and other anaerobic bacteria. The following bacteria are usually resistant to chloramphenicol: Pseudomonas aeruginosa, Acinetobacter, Enterobacter, Serratia marcescens, indole-positive Proteus, methicillin-resistant Staphylococcus and Enterococcus. This product is an antibacterial agent. Chloramphenicol is fat-soluble and enters bacterial cells by diffusion, and reversibly binds to the 50S subunit of the bacterial ribosome, which blocks the growth of the peptide chain (possibly due to the inhibition of the action of transpeptidase), thereby inhibiting the formation of the peptide chain and preventing protein synthesis.

It can improve the blood supply to the vertebral artery, regulate the function of the vestibular system, inhibit the vomiting center, and have anti-vertigo and antiemetic effects.

This product can improve the blood supply to the vertebral basilar artery, regulate the function of the vestibular system, inhibit the vomiting center, and has anti-vertigo and antiemetic effects.

This product can improve the blood supply to the vertebral basilar artery, regulate the function of the vestibular system, inhibit the vomiting center, and has anti-vertigo and antiemetic effects.

This product can improve the blood supply to the vertebral basilar artery, regulate the function of the vestibular system, inhibit the vomiting center, and has anti-vertigo and antiemetic effects.

This product can improve the blood supply to the vertebral basilar artery, regulate the function of the vestibular system, inhibit the vomiting center, and has anti-vertigo and antiemetic effects.

This product can improve the blood supply to the vertebral basilar artery, regulate the function of the vestibular system, inhibit the vomiting center, and has anti-vertigo and antiemetic effects.

Participates in the formation of bones and the reconstruction of bone tissue after fracture, muscle contraction, nerve transmission, coagulation process and reduces the permeability of capillaries, etc.

It has a direct relaxant effect on the smooth muscles of the respiratory tract; it achieves bronchial dilation in part by releasing endogenous adrenaline and norepinephrine; as a purine receptor blocker, it can counteract the contractile effect of adenine and other substances on the respiratory tract; it enhances the contractility of the diaphragm and improves respiratory function.